title: Follicular lymphomas--a review of treatment modalities.
abstract: Follicular lymphoma is the most common low-grade non Hodgkin's lymphoma and represent an homogeneous entity as defined by pathological, molecular and clinical data. This indolent disease is characterised by a slow growth pattern with possible spontaneous regression, is often disseminated but remains incurable with available treatments when disseminated. For localised stages, involved field radiotherapy remains the standard choice but other approaches remain to be investigated. In advanced disease, chemotherapy has been demonstrated to produce high response rates but recent trials with new treatment strategies including interferon and monoclonal antibodies may improve the current situation. In this article, we will review treatment of follicular lymphomas, specially emphasising published phase III trials.
authors.affiliation: Institut Bergonié, Comprehensive Cancer Centre, 180, rue de Saint-Genès, F-33076 Cedex, Bordeaux, France. soubeyran_p@bergonie.org
authors.forename: P
authors.initials: P
authors.lastname: Soubeyran
authors.forename: M
authors.initials: M
authors.lastname: Debled
authors.forename: N
authors.initials: N
authors.lastname: Tchen
authors.forename: P
authors.initials: P
authors.lastname: Richaud
authors.forename: A
authors.initials: A
authors.lastname: Monnereau
authors.forename: F
authors.initials: F
authors.lastname: Bonichon
authors.forename: H
authors.initials: H
authors.lastname: Eghbali
mesh_terms: D006801:Humans; D008224:Lymphoma, Follicular / Q000473:pathology / Q000503:physiopathology / Q000628:therapy*